Dr. Jiayi Huang, M.D.
Claim this profileWashington University School of Medicine
Studies Glioblastoma
Studies Brain Tumor
18 reported clinical trials
35 drugs studied
About Jiayi Huang, M.D.
Education:
- Earned a B.A. in Biochemistry from Brandeis University, Waltham, MA (2001).
- Received an M.D. from the University of Massachusetts Medical School, Worcester, MA (2007).
Experience:
- Completed a Residency in Radiation Oncology at William Beaumont Hospital, Royal Oak, MI (2012).
- Holds the academic title of Associate Professor, Radiation Oncology; Chief, CNS/Gamma Knife Service.
- Specializes in Radiation Oncology with a clinical focus on brain tumors, skull base tumors, spinal tumors, and lymphoma.
- Affiliated with Barnes-Jewish Hospital and Christian Hospital, actively involved in research on molecular imaging and cancer stem cells.
Area of expertise
1Glioblastoma
IDH negative
Stage IV
MET positive
2Brain Tumor
IDH positive
1p/19q positive
1p/19q negative
Affiliated Hospitals
Clinical Trials Jiayi Huang, M.D. is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Pulsed Radiotherapy
for Brain Cancer
This trial studies the side effects of a new method of giving radiation in small, timed doses, in patients with certain types of brain tumors who have had earlier treatments. This approach may be more effective and less harmful.
Recruiting1 award N/A9 criteria
More about Jiayi Huang, M.D.
Clinical Trial Related2 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Jiayi Huang, M.D. has experience with
- Temozolomide
- Surgery
- Radiation Therapy
- Bevacizumab
- Photon Beam Radiation Therapy
- Proton Beam Radiation Therapy
Breakdown of trials Jiayi Huang, M.D. has run
Glioblastoma
Brain Tumor
Astrocytoma
Meningioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jiayi Huang, M.D. specialize in?
Jiayi Huang, M.D. focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are Stage IV.
Is Jiayi Huang, M.D. currently recruiting for clinical trials?
Yes, Jiayi Huang, M.D. is currently recruiting for 8 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Jiayi Huang, M.D. has studied deeply?
Yes, Jiayi Huang, M.D. has studied treatments such as Temozolomide, Surgery, Radiation Therapy.
What is the best way to schedule an appointment with Jiayi Huang, M.D.?
Apply for one of the trials that Jiayi Huang, M.D. is conducting.
What is the office address of Jiayi Huang, M.D.?
The office of Jiayi Huang, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.